latest news releases from the newsroom
Olicom Reports Full-Year 2002 Financial Results
COPENHAGEN, Denmark, Feb. 7, 2003 (PRIMEZONE) -- For 2002, Olicom's (Other OTC:OLCMF) net result was a loss of DKK 18.2 million ($2.6 million), which is in accordance with the previously announced expectations for 2002. The result of primary operations was a loss of DKK 39.5 million ($5.6 million), of which write-down of investments in portfolio companies amounted to DKK 22.8 million ($3.2 million). The result of discontinued business was a profit of DKK 15 million ($2.1 million), which primarily relates to the termination of lease commitments with lower costs than originally expected and the refund of customs duty.
Sapa: Board Membership Proposals
STOCKHOLM, Sweden, Feb. 7, 2003 (PRIMEZONE) -- In view of the upcoming Annual General Meeting of Sapa AB (Other OTC:SPKKF) (Stockholm:SAPA) to be held on Friday, April 11, 2003, shareholders representing 85 per cent of the voting rights in Sapa have informed the Company that they intend to propose the re-election of the following board members: Per-Olof Eriksson, Anders Carlberg, Ole Enger, Lennart Evrell, Leif Gustafsson, Mats Qviberg and Staffan Bohman.
Continued International Expansion: Sectra Establishes an Office in Australia
LINKOPING, Sweden, Feb. 7, 2003 (PRIMEZONE) -- The Swedish IT and medical technology company Sectra (Other OTC:SSBBF) (Stockholm:SECTb) announces the opening of a new office in Sydney, Australia. This move will allow Sectra to give local service to its partners and users in the Australian and New Zealand diagnostic imaging market
Medivir's MIV-210 Enters Phase I Multiple Dose Study
HUDDINGE, Sweden, Feb. 7, 2003 (PRIMEZONE) -- The continued phase I clinical study, multiple dosing in healthy volunteers, for the antiviral MIV-210 has now started. The study is being performed in the United Kingdom and is expected to be completed during the second half of 2003.
Jan Werne New CEO of Sign On
STOCKHOLM, Sweden, Feb. 7, 2003 (PRIMEZONE) -- The board of Sign On (Other OTC:SGONF) has decided to appoint Jan Werne as the new CEO of Sign On. Werne will take up the post with immediate effect.